Vaccine-Related Journal Articles
Vaccine Concerns
Alternative medicine MMR Religious concerns
Autism Multiple injections Thimerosal
Autism 2008 Archive 2003-1998
Mercury Levels in Newborns and Infants after Receipt of Thimerosal-Containing Vaccines
Authors: Pichichero ME, Gentile A, Giglio N, et al
Source: Pediatrics, February 2008; 121(2) e208-214
Abstract
Mercury, Vaccines, And Autism: One Controversy, Three Histories
Author: Baker JP
Source: American Journal of Public Health, February 2008;98(2): 244-253
Abstract
Association between Microdeletion and Microduplication at 16p11.2 and Autism
Authors: Weiss LA, Shen Y, Korn JM, et al
Source: N Engl J Med, January 9, 2008 [Epub ahead of print]
HTML |  PDF
Continuing Increases in Autism Reported to California's Developmental Services System: Mercury in Retrograde
Authors: Schechter R, Grether JK
Source: Arch Gen Psychiatry, January 2008; 65(1):19-24
HTML |  PDF
Thimerosal Disappears but Autism Remains (editorial)
Author: Fombonne E
Source: Arch Gen Psychiatry, January 2008; 65(1):15-16 
Abstract
Autism 2007 back to top
Lack of Association between Rh Status, Rh Immune Globulin in Pregnancy and Autism
Authors: Miles JH, Takahashi TN
Source: Am J Med Genet, May 16, 2007 [Epub ahead of print]
Abstract
Maternal and Paternal Age and Risk of Autism Spectrum Disorders
Authors: Croen LA, Najjar DV, Fireman B, Grether JK
Source: Arch Pediatr Adolesc Med, April 2007; 161:334-340
Abstract
What Makes an Expert?
Author: Brian Deer
Source: BMJ, March 31, 2007; 334(7595):666-667
Abstract
Strong Association of De Novo Copy Number Mutations with Autism
Authors: Sebat J, Lakshmi B, Malhotra D, et al
Source: Science, March 15, 2007 [Epub ahead of print]
Abstract
Prevalence of Autism Spectrum Disorders - Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2000; Prevalence of Autism Spectrum Disorders - Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2002; and Evaluation of a Methodology for a Collaborative Multiple Source Surveillance Network for Autism Spectrum Disorders -Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2002
Source: MMWR, February 9, 2007; SS-1:1-44
PDF
MMR-Vaccine and Regression in Autism Spectrum Disorders: Negative Results Presented from Japan
Authors: Uchiyama T, Kurosawa M, Inaba Y
Source: J Autism Dev Disord, February 2007; 37(2):210-217
Abstract
Diphtheria, Pertussis, Poliomyelitis, Tetanus, and Haemophilus influenzae Type b Vaccinations and Risk of Eczema and Recurrent Wheeze in the First Year of Life
Authors: Kummeling I, Thijs C, Stelma F, et al
Source: Pediatrics, February 2007; 119:367-373
Abstract
Mutations in the Gene Encoding the Synaptic Scaffolding Protein SHANK3 are associated with Autism Spectrum Disorders
Authors: Durand CM, Betancur C, Boeckers TM, et al
Source: Nat Genet, January 2007; 39(1):25-27
Abstract
Autism 2006 back to top
Myth: The Risks of Immunizing Children Often Outweigh the Benefits
Source: Canadian Health Services Research Foundation (CHSRF), December 2006
PDF
A Genetic Variant that Disrupts MET Transcription is Associated with Autism
Authors: Campbell DB, Sutcliffe JS, Ebert PJ, et al
Source: Proc Natl Acad Sci USA, October 19, 2006 [Epub ahead of print]
Related NIH news release
Abstract
Has the Measles-Mumps-Rubella Vaccine Been Fully Exonerated? (Commentary)
Author: Katz SL
Source: Pediatrics, October 2006, Vol. 118(4):1744-1745
Abstract
No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells from Children with Autism Spectrum Disorder
Authors: D'Souza Y, Fombonne E, Ward BJ
Source: Pediatrics, October 2006, Vol. 118(4):1664-1675
Abstract
Advancing Paternal Age and Autism
Authors: Reichenberg A, Gross R, Weiser M, et al
Source: Arch Gen Psychiatry, September 2006, Vol. 63(9):1026-1032
Abstract
Mutations in the Ribosomal Protein Gene RPL10 Suggest a Novel Modulating Disease Mechanism for Autism
Authors: Klauck SM, Felder B, Kolb-Kokocinski A, et al
Source: Mol Psychiatry, August 29, 2006 [Epub ahead of print]
Abstract
Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links with Immunizations
Authors: Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D
Source: Pediatrics, July 2006, Vol. 118(1):e139-e150
Abstract
Autism and Family Home Movies: A Comprehensive Review
Authors: Palomo R, Belinchon M, Ozonoff S
Source: J Dev Behav Pediatr, April 2006, Vol. 27(2 Suppl):S59-S68
Abstract
Early Language and Communication Development of Infants Later Diagnosed with Autism Spectrum Disorder
Authors: Mitchell S, Brian J, Zwaigenbaum L, et al
Source: J Dev Behav Pediatr, April 2006, Vol. 27(2 Suppl):S69-S78
Abstract
Examination of the Time Between First Evaluation and First Autism Spectrum Diagnosis in a Population-Based Sample
Authors: Wiggins LD, Baio J, Rice C
Source: J Dev Behav Pediatr, April 2006, Vol. 27(2 Suppl):S79-S87
Abstract
Deaths Associated with Hypocalcemia from Chelation Therapy—Texas, Pennsylvania, and Oregon, 2003-2005
Source: MMWR, March 3, 2006, Vol. 55(8):204-7
Abstract
Parental Perspectives on the Causes of an Autism Spectrum Disorder in their Children
Authors: Mercer L. Creighton S. Holden JJ. Lewis ME.
Source: Journal of Genetic Counseling, February 2006, Vol. 15(1):41-50
Abstract
Vaccine Adverse Event Reporting System Reporting Source: A Possible Source of Bias in Longitudinal Studies
Authors: Goodman MJ, Nordin J
Source: Pediatrics, February 2006, Vol. 117(2):387-390
Abstract
Autism 2005-2004 back to top
Risk Factors for Autism: Perinatal Factors, Parental Psychiatric History, and Socioeconomic Status
Authors: Larsson HJ, Easton WW, Madsen KM, et al.
Source: American Journal of Epidemiology, May 15, 2005, Vol. 161(10):916-925
Abstract
The Incidence of Autism in Olmsted County, Minnesota, 1976-1997
Authors: Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ
Source: Archives of Pediatric and Adolescent Medicine, January 2005, Vol. 159(1):37-44
Abstract
No Effect of MMR Withdrawal on the Incidence of Autism: A Total Population Study
Authors: Honda H, Shimizu Y, Rutter M
Source: Journal of Child Psychology & Psychiatry, Online Early Release
Abstract
MMR Vaccination and Pervasive Developmental Disorders: A Case-Control Study
Authors: Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, Hall AJ
Source: Lancet, September 11, 2004, Vol. 364(9438):963-9
Abstract
Relationship Between MMR Vaccine and Autism
Authors: Klein KC, Diehl EB
Source: The Annals of Pharmacotherapy, July-August 2004, Vol. 38(7-8):1297-1300
Abstract
Vaccine Risk Perception Among Reporters of Autism after Vaccination: Vaccine Adverse Event Reporting System 1990-2001
Authors: Woo EJ, Ball R, Bostrom A, et al.
Source: American Journal of Public Health
Abstract
Immunization Safety Review: Vaccines and Autism
Source: Institute of Medicine (IOM)
HTML
The Genetics of Autism
Authors: Muhle R, Trentacoste SV, Rapin I
Source: Pediatrics, May 2004, Vol. 113(5):e472-86
Abstract
Retraction of an Interpretation
Source: The Lancet, March 6, 2004, Vol. 363(9411)
You must register (no charge) to access this article.
HTML
The Lessons of MMR
Source: The Lancet, March 6, 2004, Vol. 363(9411)
You must register (no charge) to access this article.
HTML
A Statement by the Editors of the Lancet
Source: The Lancet, February 28, 2004
PDF
MMR Vaccine and Autism: An Update of the Scientific Evidence
Authors: DeStefano F, Thompson WW
Source: Expert Review of Vaccines, February 2004, Vol. 3(1):19-22
Abstract
Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects: A Population-Based Study in Metropolitan Atlanta
Authors: DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C
Source: Pediatrics, February 2004, Vol. 113(2):259-266
Abstract
MMR Vaccination and Autism: What Is the Evidence for a Causal Association?
Authors: Madsen KM, Vestergaard M
Source: Drug Safety, 2004, Vol. 27(12):831-840
Abstract
Autism Archive back to top
Autism journal articles 2003-1998
Immunization Action Coalition  |  1573 Selby Avenue  |  St. Paul MN 55104
contact: admin@immunize.org  |  www.immunize.org
tel: 651.647.9009  |  fax: 651.647.9131